Supira Medical's Next Generation Percutaneous Ventricular Assist Device (pVAD) System to be Highlighted in a Live Case and Multiple Sessions at TCT23

Supira's technology features a novel low profile, high continuous flow design that aims to provide full hemodynamic support for high-risk percutaneous coronary interventions (HRPCI) and cardiogenic shock (CS) patients with a single device

Related Keywords

Brazil ,Carlos Campos ,Sãpaulo ,San Francisco ,California ,United States ,Nitin Salunke ,Fabios Brito Jr ,Alexandre Abizaid ,Gagan Singh ,Azeem Latib ,Structural Heart Interventions At Montefiore Health Systems ,Medtech Innovation Forum ,Supira Medical Inc ,Supira Medical ,Cardiovascular Therapeutics ,Supira System ,Temporary Mechanical Circulatory Support ,Balancing Clinical Needs ,Presentation Theater ,Coronary Artery Disease ,Novel Ventricular Assist ,Coronary Theater ,Exhibition Level ,Section Head ,Interventional Cardiology ,Structural Heart Interventions ,Montefiore Health Systems ,Nearly Human ,Supira Percutaneous Ventricular Assist ,Featured Technological Trends ,Clinical Science Theatre ,